Peptidylglycine α-amidating monooxygenase- and proadrenomedullin-derived peptide-associated neuroendocrine differentiation are induced by androgen deprivation in the neoplastic prostate

International Journal of Cancer

Volumn 94, Issue 1, 2001, Pages 28-34

  Jimnez, Nuria ^a   Jongsma, Johan ^b   Calvo, Alfonso ^a   Van Der Kwast, Theodorus H ^b   Treston, Anthony M ^c   Cuttitta, Frank ^c   Schrder, Fritz H ^b   Montuenga, Luis M ^a   Van Steenbrugge, Gert J ^b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Adrenomedullin; Androgen blockade; Neuroendocrine; Peptidylglycine amidating monooxygenase; Peptidylglycine hydroxylating monooxygenase; Proadrenomedullin N terminal 20 peptide; Prostate cancer

Indexed keywords

ALPHA AMIDATING ENZYME; ANDROGEN; ANTIANDROGEN; CYPROTERONE ACETATE; FLUTAMIDE; PROADRENOMEDULLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ANALYSIS; HUMAN; HUMAN TISSUE; MALE; MOUSE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

ADRENOMEDULLIN; ANDROGEN ANTAGONISTS; ANIMALS; CELL DIFFERENTIATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MIXED FUNCTION OXYGENASES; MULTIENZYME COMPLEXES; NEOPLASM TRANSPLANTATION; NEUROSECRETORY SYSTEMS; PEPTIDE FRAGMENTS; PEPTIDES; PROSTATE; PROSTATIC NEOPLASMS; PROTEINS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0035480060     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1436     Document Type: Article

References (37)

1. The National Cancer Data Base report on longitudinal observations on prostate cancer
2. Endocrine-paracrine cells of the prostate and prostatic urethra: An ultrastructural study
3. Peptide-hormone- and serotonin-immunoreactive tumor cells in carcinoma of the prostate
4. Argentaffin cells in prostatic: Differentiation from lipofuscin and melanin in prostatic epithelium
5. Immunohistochemical localization of chromogranins A and B and secretogranin II in normal, hyperplastic and neoplastic prostate
6. Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic and therapeutic implications
7. Bombesin stimulates growth of human prostatic cancer cells in vitro
8. Direct inhibitory effect of somatostatin on the growth of the human prostatic cell line LNCaP: Possible mechanism of action
9. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP)
10. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin
11. Expression of adrenomedullin and proadrenomedullin N-terminal 20 peptide in human and rat prostate
12. Distribution of adrenomedullin (AM), proadrenomedullin N-terminal 20 peptide, and AM mRNA in the rat gastric mucosa by immunocy-tochemistry and in situ hybridization
13. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla
14. Proadrenomedullin NH(2)-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings
15. Proadrenomedullin N-terminal 20 peptide inhibits adrenocorticotropin secretion from cultured pituitary cells, possibly via activation of a potassium channel
16. Proadrenomedullin N-terminal 20 peptide (PAMP) inhibits proliferation of human neuroblastoma TGW cells
17. C-terminal amidated peptides: Production by the in vitro enzymatic amidation of glycine-extended peptides and the importance of the amide to bioactivity
18. Peptidyl-alpha-hydroxyglycine alpha-amidating lyase. Purification, characterization, and expression
19. Tissue specific expression of rat peptidylglycine alpha-amidating monooxygenase activity and mRNA
20. Distribution of peptidyl-glycine alpha-amidating mono-oxygenase (PAM) enzymes in normal human lung and in lung epithelial tumors
21. Androgen deprivation of the PC-310 human prostate cancer model system induces neuroendocrine differentiation
22. Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model
23. Localization of amidating enzymes (PAM) in rat gastrointestinal tract
24. Carcinoma of the prostate
25. Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate
26. Neuroendocrine differentiation in prostatic carcinoma: An update
27. Development of seven new human prostate tumor xenograft models and their histopathological characterization
28. Human prostatic adenocarcinoma: Some characteristics of a serially transplantable line in nude mice (PC 82)
29. Neuroendocrine differentiation in human prostatic tumor models
30. Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action
31. The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long-term follow-up study with patients treated by radical prostatectomy
32. The neuroendocrine cell population of the human prostate gland
33. Neuroendocrine differentiation in prostatic carcinoma
34. Expression of proadrenomedullin derived peptides in the mammalian pituitary: Co-localization of follicle stimulating hormone and proadrenomedullin N-terminal 20 peptide-like peptide in the same granules of the gonadotropes
35. Differential expression of proadrenomedullin gene products by alternative splicing
36. Adrenomedullin gene is abundantly expressed and directly regulated by androgen in the rat ventral prostate
37. Expression and androgen regulation of C-CAM cell adhesion molecule isoforms in rat dorsal and ventral prostate